Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Xerox Corporation (“Xerox”) or the “Company”) (NYSE: XRX) concerning the Company and its officers’ possible violations of federal securities laws.

On October 26, 2015, Xerox disclosed disappointing third quarter 2015 financial results, citing lost revenues in its much-touted Health Enterprise segment, including from the termination of certain Health Enterprise projects in California and Montana. According to Xerox, the loss of these contracts would result in lower revenues in each of the next three quarters. Additionally, the Company announced plans for a strategic review of the Company's business portfolio.

On this news, shares of Xerox fell to approximately $9 per share on October 27, 2015.

If you purchased Xerox securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.